<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.marketbeat.com/feed/</title><link>https://www.marketbeat.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Wed, 15 Oct 2025 19:54:13 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Palantir’s New Healthcare Deal Boosts AI and Data Reach</title><link>https://www.marketbeat.com/stock-ideas/palantirs-new-healthcare-deal-boosts-ai-and-data-reach/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>Palantir’s new OneMedNet partnership expands its AI and healthcare data footprint, fueling commercial growth and bullish sentiment ahead of earnings</description><pubDate>Wed, 15 Oct 2025 19:16:00 GMT</pubDate></item><item><title>GM's Billion-Dollar Bruise: GM's Strategic Pivot Makes It a Buy</title><link>https://www.marketbeat.com/stock-ideas/gms-billion-dollar-bruise-gms-strategic-pivot-makes-it-a-buy/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>General Motors' strategic pivot on its EV plans, backed by a dominant and highly profitable core business, signals a disciplined focus on long-term va...</description><pubDate>Wed, 15 Oct 2025 18:09:00 GMT</pubDate></item><item><title>Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead</title><link>https://www.marketbeat.com/stock-ideas/novo-nordisks-akero-therapeutics-buy-targets-eli-lillys-lead/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Novo Nordisk’s $4.7B Akero deal boosts its metabolic health pipeline, targeting Eli Lilly’s lead in obesity and liver disease treatments</description><pubDate>Wed, 15 Oct 2025 16:15:00 GMT</pubDate></item><item><title>ASML Can Hit New Highs, But It Won’t Be Easy: Here’s Why</title><link>https://www.marketbeat.com/stock-ideas/asml-can-hit-new-highs-but-it-wont-be-easy-heres-why/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>ASML is on track to reach record high stock prices, but the move won't come easily as institutional interest is tepid and headwinds remain.</description><pubDate>Wed, 15 Oct 2025 16:03:00 GMT</pubDate></item><item><title>Vertiv Stock Surges on Strategic CFO Hire and AI Momentum</title><link>https://www.marketbeat.com/originals/vertiv-stock-surges-on-strategic-cfo-hire-and-ai-momentum/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Vertiv's appointment of an operationally-focused CFO signals a strategic shift to translate its rapid AI-driven growth into enhanced profitability.</description><pubDate>Wed, 15 Oct 2025 15:41:00 GMT</pubDate></item></channel></rss>